BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 865 filers reported holding BAXTER INTL INC in Q3 2016. The put-call ratio across all filers is 0.50 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $400,988 | -19.1% | 10,625 | -2.3% | 0.11% | -16.2% |
| Q2 2023 | $495,465 | -30.3% | 10,875 | -37.9% | 0.13% | -33.0% |
| Q1 2023 | $710,408 | -37.7% | 17,515 | -21.7% | 0.19% | -40.5% |
| Q4 2022 | $1,139,893 | -11.6% | 22,364 | -6.6% | 0.33% | -20.5% |
| Q3 2022 | $1,289,000 | -17.9% | 23,939 | -2.1% | 0.41% | -9.3% |
| Q2 2022 | $1,570,000 | -17.7% | 24,449 | -0.6% | 0.45% | -4.6% |
| Q1 2022 | $1,907,000 | -18.3% | 24,589 | -9.5% | 0.47% | -12.9% |
| Q4 2021 | $2,333,000 | +4.7% | 27,175 | -1.9% | 0.54% | -4.6% |
| Q3 2021 | $2,228,000 | -4.1% | 27,705 | -4.0% | 0.57% | -4.0% |
| Q2 2021 | $2,324,000 | -6.2% | 28,865 | -1.8% | 0.59% | -14.8% |
| Q1 2021 | $2,478,000 | +3.7% | 29,385 | -1.3% | 0.70% | -2.8% |
| Q4 2020 | $2,390,000 | -7.1% | 29,785 | -6.9% | 0.72% | -13.0% |
| Q3 2020 | $2,572,000 | -8.3% | 31,985 | -1.8% | 0.82% | -14.7% |
| Q2 2020 | $2,806,000 | +3.8% | 32,585 | -2.1% | 0.97% | -9.0% |
| Q1 2020 | $2,702,000 | -3.8% | 33,285 | -1.0% | 1.06% | +28.6% |
| Q4 2019 | $2,810,000 | -6.1% | 33,610 | -1.7% | 0.83% | -13.3% |
| Q3 2019 | $2,991,000 | +5.2% | 34,195 | -1.5% | 0.95% | +5.0% |
| Q2 2019 | $2,844,000 | -0.4% | 34,720 | -1.1% | 0.91% | -2.7% |
| Q1 2019 | $2,855,000 | +22.7% | 35,115 | -0.6% | 0.93% | +9.4% |
| Q4 2018 | $2,326,000 | -17.0% | 35,335 | -2.9% | 0.85% | -10.0% |
| Q3 2018 | $2,804,000 | +0.3% | 36,375 | -4.0% | 0.95% | -26.2% |
| Q2 2018 | $2,796,000 | -40.9% | 37,872 | -47.9% | 1.28% | -35.6% |
| Q1 2018 | $4,730,000 | +0.7% | 72,717 | +0.1% | 2.00% | +0.3% |
| Q4 2017 | $4,698,000 | +2.2% | 72,678 | -0.8% | 1.99% | -3.7% |
| Q3 2017 | $4,598,000 | +3.3% | 73,277 | -0.3% | 2.06% | -1.0% |
| Q2 2017 | $4,449,000 | +9.5% | 73,481 | -6.2% | 2.08% | +17.8% |
| Q1 2017 | $4,062,000 | +16.9% | 78,319 | -0.1% | 1.77% | +12.5% |
| Q4 2016 | $3,475,000 | -1.8% | 78,368 | +5.5% | 1.57% | -9.1% |
| Q3 2016 | $3,537,000 | +5.2% | 74,297 | -0.1% | 1.73% | +4.0% |
| Q2 2016 | $3,363,000 | -1.8% | 74,361 | -1.9% | 1.66% | +2.1% |
| Q1 2016 | $3,423,000 | +2.9% | 75,816 | -13.1% | 1.63% | +8.7% |
| Q4 2015 | $3,327,000 | +11.3% | 87,210 | -4.2% | 1.50% | +5.4% |
| Q3 2015 | $2,989,000 | -21.8% | 91,014 | +66.5% | 1.42% | -17.4% |
| Q2 2015 | $3,822,000 | +15.6% | 54,649 | +13.2% | 1.72% | +18.8% |
| Q1 2015 | $3,306,000 | -3.2% | 48,264 | +3.6% | 1.45% | -0.4% |
| Q4 2014 | $3,415,000 | +0.6% | 46,589 | -1.5% | 1.46% | +0.7% |
| Q3 2014 | $3,396,000 | +12.8% | 47,314 | +13.6% | 1.44% | +23.9% |
| Q2 2014 | $3,010,000 | +344.6% | 41,649 | +352.8% | 1.17% | +300.7% |
| Q1 2014 | $677,000 | -2.0% | 9,199 | -7.3% | 0.29% | +0.7% |
| Q4 2013 | $691,000 | +4.5% | 9,924 | -1.5% | 0.29% | -2.7% |
| Q3 2013 | $661,000 | -9.8% | 10,074 | -4.7% | 0.30% | -6.0% |
| Q2 2013 | $733,000 | – | 10,574 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERATION INVESTMENT MANAGEMENT LLP | 21,171,371 | $1,817,350,000 | 7.47% |
| Soditic Asset Management LLP | 147,620 | $12,672,000 | 6.53% |
| NUANCE INVESTMENTS, LLC | 4,084,218 | $350,589,000 | 6.17% |
| PRAGMA GESTAO DE PATRIMONIO LTD | 145,000 | $12,447 | 5.96% |
| Veritas Asset Management LLP | 12,222,261 | $1,049,159,000 | 5.89% |
| Pavadi Capital LLC | 72,782 | $6,248,000 | 4.74% |
| Sonen Capital LLC | 48,907 | $4,198,000 | 4.06% |
| Glenview Capital Management | 2,182,422 | $187,339,000 | 3.99% |
| Dash Acquisitions Inc. | 103,963 | $8,924,000 | 3.87% |
| Avidity Partners Management LP | 1,765,000 | $151,508,000 | 3.21% |